The Spill
Stride director Dylan G. Haggart reported seven open-market buys of Stride stock at prices from $74.07 to $78.51, all made through Fivespan Partners, the investment firm where he is co-founder, managing partner and chief investment officer. The insider filing (Form 4) hit EDGAR at 8:34 p.m. ET on Nov. 3, the same day as the last two lots, and the position it reports now stands at 2,127,760 shares.
Lag Clock
The last lot and the filing share a date.
Signal Check
The 10b5-1 box is not checked and no pre-set trading plan (10b5-1) appears in the footnotes, so these are code P purchases with no plan marked, and that is all the label says.
Get The Daily Spill
Every filing worth reading, with the trade date next to the filing date. Weekdays at 8 a.m. ET, about four minutes. Free forever, no paywall.
Get it freeWhat the filing shows
Seven lots, 228,057 shares, $17,573,121.28, at $74.07 to $78.51 a share. The common stake was 1,899,703 shares before the first lot and 2,127,760 after the last, a 12% top-up on what was held before the buy.
Every share is reported as indirect. The footnotes say the stock includes shares owned directly by Fivespan Partners Fund, Ltd, that Fivespan Partners, LP manages that fund, and that Haggart runs both the firm and its general partner, Fivespan Partners GP, LLC. The form is filed jointly by Haggart, Fivespan and Fivespan GP, and each disclaims ownership except to the extent of a pecuniary interest. The footnotes spend more words disclaiming the shares than describing them.
There are no option or RSU rows. All seven transactions:
| Date | Shares | Price | Value |
|---|---|---|---|
| Oct. 30, 2026 | 4,200 | $78.51 | $329,742 |
| Oct. 30, 2026 | 50,000 | $78.33 | $3,916,500 |
| Nov. 2, 2026 | 12,500 | $77.30 | $966,250 |
| Nov. 2, 2026 | 50,000 | $77.23 | $3,861,500 |
| Nov. 2, 2026 | 75,000 | $77.01 | $5,775,750 |
| Nov. 3, 2026 | 5,000 | $74.07 | 5,000 × $74.07 |
| Nov. 3, 2026 | 31,357 | $75.04 | $2,353,029.28 |
The Other Side
A board member putting $17.6 million into his own company's stock in three days looks like the kind of insider buy the headlines are built on. The filing frames it as a fund trade.
Fivespan already held 1,899,703 shares before Oct. 30, and the week's buying added 12% to that. The lots were round, 50,000 and 75,000 shares among them, which is consistent with a manager working an order and proof of nothing.
The form also doesn't separate Haggart's money from his investors'. The footnotes say Fivespan and Fivespan GP may be a director by deputization, meaning the firm sits on the board through him, and they stop at "pecuniary interest" when it comes to who owns what.
What it can't tell you
- Why Fivespan bought. The form does not say why. A Form 4 reports the trade, the price and the holding, nothing about the reasoning.
- How big a slice of Fivespan this is. The filing gives the Stride position, not the fund's size, so there's no way to say whether 2,127,760 shares is a large or small part of what Fivespan runs.
- Whether the buying is finished. The report covers Oct. 30 through Nov. 3 and nothing after.
What to watch
Any further Form 4 from Haggart or Fivespan, due within two business days of the next trade; the 8:34 p.m. ET same-day filing sets the pace to compare against. The next filing's position line will show whether 2,127,760 shares is where the fund settled.
Original sources
Drafted with software from the public filing and checked against it before publishing; K. Song is the editor responsible for every story. Educational reporting from public filings, not investment advice. Filings can be late, incomplete or amended; check the original source and dates. Free forever: no paywall, no paid tier. Advertising and sponsors pay for it, and they do not pick the stories. How we work · Corrections: [email protected]
Tickers in this story: $LRN ( ▼ 0.87% )